Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Conquering oncogenic KRAS and its bypass mechanisms

Theranostics(2022)10.7150/thno.71260Source: DataRank Database

Conquering oncogenic KRAS and its bypass mechanisms is a research paper published in Theranostics (2022). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (21)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Yingshuang Wang,Pingping Hou ORCID

Live enrichment

PubMed:35966590 PMC:PMC9373815

NCI NIH HHS

Grant: K22 CA251491

NCI NIH HHS

Grant: R01 CA231349

National Institutes of Health

Grant: 1R01CA231349-01A1

Developing Novel Therapeutic Approaches Targeting Macrophages in GBM

National Institutes of Health

Grant: 1K22CA251491-01

Tumor-TAMs crosstalk enables bypass of oncogenic KRAS dependency in pancreatic cancer

goldLicense: http://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

publisherhttps://www.thno.org/v12p5691.htm

Unpaywallhttps://www.thno.org/v12p5691.pdf

Europe_PMChttps://europepmc.org/articles/PMC9373815

Europe_PMChttps://europepmc.org/articles/PMC9373815?pdf=render

https://doi.org/10.7150/thno.71260

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

HumansNeoplasmsSignal TransductionOncogenesProto-Oncogene Proteins p21(ras)Carcinogenesis

Keywords

CancerMEKKrasRafTargeted Therapy ResistanceProto-Oncogene Proteins p21(ras)CarcinogenesisNeoplasmsHumansReviewOncogenesSignal Transduction

Sustainable Development Goals